Persona Adopted: Senior Clinical Infectious Disease Consultant & Epidemiologist
Abstract
This clinical literature review (Puscast, December 2009) synthesizes high-impact data regarding viral and bacterial pathogenesis, diagnostic efficacy, and patient outcomes. Key highlights include the critical role of Vitamin D in Hepatitis C treatment response, the significant elevation of non-AIDS-defining cancer risks in HIV-positive populations, and a detailed pathological and epidemiological analysis of the 2009 H1N1 influenza pandemic. Furthermore, the review examines the displacement of MSSA by MRSA in community settings, the transient nature of Pseudomonas colonization in COPD patients, and the mortality-reducing impact of formal Infectious Disease (ID) consultations in cases of Staphylococcus aureus bacteremia. Emerging concerns regarding Extremely Drug-Resistant (XDR) and "XXDR" Tuberculosis (TB) are also addressed.
Clinical Summary: Dec 2009 Infectious Disease Literature Review
03:26 Vitamin D and Hepatitis C Response: Patients with Vitamin D deficiency exhibit significantly poorer therapeutic responses to interferon and ribavirin. Baseline Vitamin D screening is recommended for all patients undergoing Hepatitis C treatment.
04:41 HIV and Non-AIDS-Defining Malignancies: A meta-analysis of 625,000 HIV patients identifies a high incidence of non-AIDS-defining cancers. Standardized incidence ratios include 28 for anal cancer, 11 for Hodgkin’s lymphoma, and 2.6 for lung cancer, likely due to impaired immune surveillance.
06:26 2009 H1N1 Pathology and Mortality: Pregnant women accounted for 10% of reported H1N1 deaths. Autopsies of fatal cases revealed three primary patterns: classic diffuse alveolar damage (DAD), necrotizing bronchiolitis, and DAD with intense hemorrhagic components. Secondary bacterial infections were present in 38% of fatal cases.
08:12 H1N1 Transmission Dynamics: Household transmission for the pandemic strain was recorded at 13%, lower than seasonal influenza (averaging 30%). Risk is age-dependent, peaking in children (0–4 years) and diminishing significantly in adults over age 51.
09:54 Influenza Vaccine Efficacy: A randomized placebo-controlled trial in healthy adults demonstrated a 66% efficacy rate for matched strains. The vaccine remains a primary preventative measure, though it does not provide absolute protection.
12:00 Adjuvant Therapy in Pediatric Meningitis: A study of children with bacterial meningitis found that adjuvant dexamethasone or glycerol did not reduce the incidence of hearing loss; neurologic outcomes were primarily dictated by the severity of the illness at initial presentation.
13:16 Gastrointestinal Anthrax Case: A case in New Hampshire was linked to a religious drum circle utilizing African animal hides. Anthrax spores on hides can be aerosolized or ingested during handling, confirming the persistence of classic environmental exposures.
14:36 Oral Microbiome and STD Transmission: Advanced sequencing identified approximately 25,000 phylotypes in the human oral cavity. In men who have sex with men (MSM), receiving oral sex resulted in a 4.8% positivity rate for urethral Chlamydia and Gonorrhea, mirroring transmission rates of unprotected insertive anal sex.
16:41 Catheter-Associated Endocarditis: Clinical series identified S. aureus (50%), coagulase-negative staphylococci (33%), and Candida (20%) as primary pathogens. Transesophageal echocardiography (TEE) was required for diagnosis in 50% of cases.
18:25 Staphylococcus aureus Trends and ID Consultation: Epidemiological data from Olmsted County indicates that while MRSA is increasingly displacing MSSA, the overall bacteremia rate remains stable. A German study (n=521) confirmed that formal ID consultation is a protective factor, significantly reducing mortality in S. aureus bacteremia.
21:12 Pseudomonas aeruginosa in COPD: Unlike cystic fibrosis, Pseudomonas colonization in COPD patients is largely transient. Genotyping suggests the organism causes acute exacerbations but often clears spontaneously rather than establishing permanent colonization.
22:34 Infrastructure and Pneumococcal Disease: In Alaskan populations, vaccine-matched pneumococcal strains dropped by 60%, but non-vaccine serotypes increased 5–10 fold. A primary risk factor for invasive disease was the lack of piped water, emphasizing the role of hygiene in disease prevention.
24:00 Healthcare-Associated Infection (HAI) Mechanics: Switching from split-septum to mechanical valve needleless connectors led to increased infection rates in five hospitals. Similarly, subcutaneous irrigation systems for pain relief have been linked to spikes in surgical site infections.
25:30 SIRS in Emergency Departments: Patients presenting with Systemic Inflammatory Response Syndrome (SIRS) in the ER have higher 28-day mortality and a 3% risk of progressing to septic shock, necessitating high clinical vigilance.
26:36 Emerging TB Resistance: Reports from Florida indicate the emergence of "XXDR" Tuberculosis, defined as resistance to all first- and second-line anti-tuberculous agents.